| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |